Cognitive Processing in Patients Surviving Delirium. Neuropsychological, EEG and Structural Brain Correlates.

Sponsor
Rigshospitalet, Denmark (Other)
Overall Status
Suspended
CT.gov ID
NCT03562689
Collaborator
University of Copenhagen (Other)
42
1
21.1
2

Study Details

Study Description

Brief Summary

The research program explores how delirium influenced brain function in patients surviving delirium and septic encephalopathy from a non neurological specialized ICU cohort from 2013 to 2015 in Rigshospitalet (Glostrup).

Condition or Disease Intervention/Treatment Phase
  • Other: Delirium and with septic encephalopathy.

Detailed Description

The overall aim is to understand the pathophysiological mechanism in delirium and septic encephalopathy and its consequences.

For this purpose we will:
  1. Provide extensive cognitive testing. These results provide the basis for categorization of patients surviving septic encephalopathy and delirious patients.

  2. First, the investigators will examine if the differences in cognitive function is reflected in the ability of the brain to generate high-frequency electrical oscillations that accompany and underlie perception, attention, cognition, memory formation and retrieval. It will be performed by carrying out continuous EEG (cEEG) and by examination of steady-state evoked cognitive EEG responses.

  3. Second, the investigations will examine MRI, structural and diffusion tensor imaging sequences. Hippocampal, thalamic, amygdala, lentiform nucleus and cingulate cortex volumes will be determined bilaterally and will be compared between individuals with healthy brain aging and patients that survived delirium.

  4. Third, the investigators will assess plasma markers of free radical production.

Study Design

Study Type:
Observational
Anticipated Enrollment :
42 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Cognitive Processing in Patients Surviving Delirium. Neuropsychological, EEG and Structural Brain Correlates.
Actual Study Start Date :
Mar 1, 2019
Anticipated Primary Completion Date :
Aug 1, 2020
Anticipated Study Completion Date :
Dec 1, 2020

Outcome Measures

Primary Outcome Measures

  1. EEG frequencies [Through study completion, an average of 1 year]

    Automatically measurments of frequencies band

  2. MRI [Through study completion, an average of 1 year]

    Structural and diffusion tensor imaging sequences

  3. Cognitive test: Verbal-Paired Associates [Through study completion, an average of 1 year]

    Assessing explicit episodic memory performance

  4. Cognitive test: Mini-Mental State Examination (MMSE) [Through study completion, an average of 1 year]

    neurocognitive function

  5. Cognitive test: Trail-Making Test and the Symbol-Digit Modalities Test (SDMT), [Through study completion, an average of 1 year]

    Speed of processing and executive functioning

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria for the ICU cohort:
  • Age >18 years;

  • Length of stay >24 hours in the ICU.

Exclusion Criteria for the ICU cohort:
  • Expected death <24 hours;

  • Psychiatric illness; pre-existing delirium; severe dementia; cerebrovascular event <six months; major surgery <two months;

  • Non-Danish or English speaking.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rigshospitalet Glostrup Hovedstaden Denmark 2600

Sponsors and Collaborators

  • Rigshospitalet, Denmark
  • University of Copenhagen

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Olalla Urdanibia Centelles, MD; PhD Candidate, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT03562689
Other Study ID Numbers:
  • 63657
First Posted:
Jun 19, 2018
Last Update Posted:
Mar 11, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Olalla Urdanibia Centelles, MD; PhD Candidate, Rigshospitalet, Denmark
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 11, 2020